Market-Moving News for April 2nd
$ACOR
$AINC
$PIK
Biotechnology: Biological Products (No Diagnostic Substances)
Health Care
Professional Services
Consumer Discretionary
Get the next $ACOR alert in real time by email
Save time and jump to the most important pieces.
| Company | Date | Price Target | Rating | Analyst |
|---|---|---|---|---|
| 6/14/2022 | $28.00 | Outperform | Oppenheimer | |
| 12/28/2021 | $10.00 | Buy | EF Hutton |
10-Q - KIDPIK CORP. (0001861522) (Filer)
8-K - KIDPIK CORP. (0001861522) (Filer)
NT 10-Q - KIDPIK CORP. (0001861522) (Filer)
SC 13D/A - Ashford Inc. (0001604738) (Subject)
SC 13D/A - Ashford Inc. (0001604738) (Subject)
SC 13D/A - Ashford Inc. (0001604738) (Subject)
Oppenheimer initiated coverage of Ashford with a rating of Outperform and set a new price target of $28.00
EF Hutton initiated coverage of Kidpik with a rating of Buy and set a new price target of $10.00
HC Wainwright & Co. upgraded Acorda Therapeutics from Neutral to Buy and set a new price target of $10.00 from $5.00 previously
DALLAS, April 1, 2024 /PRNewswire/ -- Ashford Inc. (NYSE:AINC) ("Ashford" or the "Company") today announced that a Special Committee of independent and disinterested directors has recommended, and its Board of Directors has approved, a plan to terminate the registration of the Company's common stock under the federal securities laws following the completion of a proposed reverse stock split transaction (the "Reverse Stock Split") immediately followed by a forward stock split transaction and to delist its shares of common stock from trading on the NYSE American LLC (the "NYSE American") (the "Proposed Transaction"). It is expected that this plan would be initiated in the summer of 2024, subje
Acorda Therapeutics, Inc. (NASDAQ:ACOR) today announced that it will no longer hold its fourth quarter and year end 2023 earnings conference call originally scheduled for Monday, April 1 at 4:30 p.m. ET. The Company does expect to timely file its Annual Report on Form 10-K for the period ended December 31, 2023. About Acorda Therapeutics Acorda Therapeutics develops therapies to restore function and improve the lives of people with neurological disorders. INBRIJA® is approved for intermittent treatment of OFF episodes in adults with Parkinson's disease treated with carbidopa/levodopa. INBRIJA is not to be used by patients who take or have taken a nonselective monoamine oxidase inhibitor
DALLAS, March 26, 2024 /PRNewswire/ -- Ashford Inc. (NYSE:AINC) ("Ashford" or the "Company") today announced details for the release of its results for the first quarter ended March 31, 2024. Ashford plans to issue its earnings release for the first quarter after the market closes on Wednesday, May 8, 2024, and will host a conference call on Thursday, May 9, 2024, at 12:00 p.m. ET. The number to call for this interactive teleconference is (646) 960-0375. A replay of the conference call will be available through Thursday, May 16, 2024, by dialing (609) 800-9909 and entering the confirmation number, 1818099. The live broadcast of Ashford's quarterly conference call will be available online a
4 - Ashford Inc. (0001604738) (Issuer)
NEW YORK, NY / ACCESSWIRE / November 14, 2024 / Kidpik Corp. ("KIDPIK" or the "Company"), an online clothing subscription-based e-commerce company, today reported its financial results for the third quarter 2024 ended September 28, 2024.Third Quarter 2024 Highlights:Revenue, net: was $1.0 million, a year-over-year decrease of 69.2%.Gross margin: was 68.6%, compared to 61.1% in the third quarter of 2023.Shipped items: were 107,000 items, compared to 292,000 shipped items in the third quarter of 2023.Average shipment keep rate: decreased to 67.7%, compared to 82.6% in the third quarter of 2023.Net Loss: was $0.9 million or $0.45 per share, compared to $1.9 million or $1.20 per share in the thi
Kidpik Corp. ("KIDPIK" or the "Company"), an online clothing subscription-based e-commerce company, today reported its financial results for the second quarter 2024 ended June 29, 2024. Second Quarter 2024 Highlights: Revenue, net: was $1.1 million, a year-over-year decrease of 67.3%. Gross margin: was 66.2%, compared to 60.2% in the second quarter of 2023. Shipped items: were 135,000 items, compared to 290,000 shipped items in the second quarter of 2023. Average shipment keep rate: decreased to 74.6%, compared to 75.1% in the second quarter of 2023. Net Loss: was $1.3 million or $0.67 per share, compared to $2.0 million or $1.31 per share in the second quarter of 2023.
DALLAS, July 31, 2024 /PRNewswire/ -- Ashford Inc. (NYSE:AINC) ("Ashford" or the "Company"), today announced that in connection with its previously announced plan to withdraw and delist its common stock from trading on the NYSE American LLC stock exchange (the "NYSE American") under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), the Company effected a 1-for-10,000 reverse stock split of the Company's common stock (the "Reverse Stock Split") followed immediately by a 10,000-for-1 forward stock split of the Company's common stock (the "Forward Stock Split," together with the Reverse Stock Split, the "Transaction"), on July 29, 2024 at 5:01 p.m. Eastern Time and 5:02 p.m.
4 - Ashford Inc. (0001604738) (Issuer)
4 - Ashford Inc. (0001604738) (Issuer)
4 - Ashford Inc. (0001604738) (Issuer)
Gainers Golden Heaven Group Hldgs (NASDAQ:GDHG) shares moved upwards by 74.8% to $0.31 during Wednesday's pre-market session. The market value of their outstanding shares is at $16.1 million. Neo-Concept International (NASDAQ:NCI) shares moved upwards by 15.07% to $0.73. The company's market cap stands at $14.7 million. Singing Machine Co (NASDAQ:MICS) shares moved upwards by 11.7% to $2.1. The market value of their outstanding shares is at $13.4 million. Wah Fu Education Group (NASDAQ:WAFU) shares moved upwards by 9.99% to $2.09. The company's market cap stands at $9.2 million. Digital Brands Group (NASDAQ:DBGI) shares rose 9.82% to $1.9. The company's market cap stands at $3.7 million
Gainers Stitch Fix (NASDAQ:SFIX) stock rose 20.2% to $3.21 during Wednesday's pre-market session. The market value of their outstanding shares is at $385.7 million. As per the news, the Q3 earnings report came out yesterday. Hanesbrands (NYSE:HBI) stock rose 10.69% to $5.59. The company's market cap stands at $1.9 billion. Dream Finders Homes (NYSE:DFH) shares rose 9.36% to $28.97. The market value of their outstanding shares is at $2.7 billion. Lakeland Industries (NASDAQ:LAKE) stock increased by 7.74% to $20.31. The company's market cap stands at $149.8 million. As per the press release, Q1 earnings came out yesterday. Yoshiharu Global (NASDAQ:YOSH) stock moved upwards by 7.11% to $4.
Gainers Tuniu (NASDAQ:TOUR) shares moved upwards by 14.4% to $1.27 during Tuesday's pre-market session. The market value of their outstanding shares is at $149.9 million. As per the news, the Q1 earnings report came out today. China Liberal Education (NASDAQ:CLEU) stock increased by 8.91% to $1.1. The market value of their outstanding shares is at $3.6 million. Lixiang Education Hldg (NASDAQ:LXEH) shares increased by 7.66% to $0.34. The company's market cap stands at $3.9 million. XPEL (NASDAQ:XPEL) shares rose 6.46% to $40.98. The market value of their outstanding shares is at $1.1 billion. Kidpik (NASDAQ:PIK) shares rose 5.99% to $3.71. The market value of their outstanding shares is
INSPIRE, a global event solutions company owned by Ashford Inc. (NYSE:AINC), is pleased to announce the appointment of Sayi Puligandla as Chief Operating Officer. DALLAS, Feb. 7, 2023 /PRNewswire-PRWeb/ -- INSPIRE, a global event solutions company owned by Ashford Inc. (NYSE:AINC), is pleased to announce the appointment of Sayi Puligandla as Chief Operating Officer. In this position, Puligandla will oversee human resources, hospitality operations, information technology, and other projects to support the entire organization. Puligandla brings to INSPIRE an extensive background in the hospitality industry and valuable experience in data, analytics, and building efficient operational units for
Acorda Therapeutics, Inc. (NASDAQ:ACOR) today announced that Lauren Sabella, Chief Operating Officer, will resign from the Company effective September 30, 2022. Ms. Sabella will be working in a strategic advisory role for early-stage biotechnology companies. "We are grateful for Lauren's thirteen years of contributions as a member of Acorda's executive leadership team. Initially, she and her team led the commercial launch of AMPYRA, a novel treatment for multiple sclerosis. The tremendous success of that product allowed Acorda to invest in additional clinical development programs, including INBRIJA for Parkinson's disease," said Ron Cohen, M.D., Acorda's President and CEO. "Lauren has been
DALLAS, May 23, 2022 /PRNewswire/ -- Ashford Securities LLC ("Ashford Securities"), a wholly owned subsidiary of Ashford Inc. (NYSE:AINC) ("Ashford"), is pleased to announce that Ben Hilgers has been promoted to Senior Vice President, National Sales Manager. C. Jay Steigerwald III, President and Head of Distribution at Ashford Securities commented, "I have known Ben for almost twenty years and am excited to have him lead our sales efforts. Ben has a tremendous amount of experience with multiple types of products and, more importantly, has a great reputation in the industry. Ben's affable nature is complemented by his creativity and strategic thinking. We look forward to his leadership drivin